FDA blames fall in foreign inspections on investigator shortage
The US FDA attributes decline in foreign inspections from 2016 to 2018 to inability to fill vacancies.
The US FDA attributes decline in foreign inspections from 2016 to 2018 to inability to fill vacancies.
Sanofi plans “optimization of CMOs and suppliers” as new CEO targets €2bn in savings by 2022.